Some types of eye cancer are hereditary, but most are not. The answer depends heavily on which type of eye cancer you’re asking about. Retinoblastoma, the most common eye cancer in children, is hereditary in roughly 40% of cases. Uveal melanoma, the most common eye cancer in adults, is usually sporadic, but a small percentage of cases run in families due to an inherited gene mutation.
Inherited vs. Sporadic Eye Cancer
Every cancer starts with a change in DNA, but how that change happens matters. In hereditary eye cancers, a child is born with a damaged gene already present in every cell of their body, passed down from a parent through the egg or sperm. That child starts life one step closer to cancer because only one additional DNA change in the eye is needed to trigger tumor growth.
In sporadic (non-hereditary) eye cancers, both DNA changes happen randomly in eye cells after birth. There’s no family connection, and the mutation can’t be passed to future children. About 55% to two-thirds of retinoblastoma cases fall into this category, meaning the child’s parents don’t carry the gene and the mutation appeared for the first time in the child’s own cells.
Retinoblastoma: The Most Common Hereditary Eye Cancer
Retinoblastoma is a cancer of the retina that almost exclusively affects young children. About one-third to 40% of all retinoblastoma cases are hereditary, caused by an inherited mutation in a gene called RB1. This gene normally acts as a brake on cell growth. When a child inherits one broken copy, it takes only one more random mutation in a retinal cell for a tumor to form. This concept, known as the “two-hit hypothesis,” was first proposed in 1971 and remains the foundation for understanding this cancer.
Hereditary retinoblastoma follows an autosomal dominant inheritance pattern. That means a parent who carries the mutation has a 50% chance of passing it to each child. Children who inherit the mutation often develop tumors in both eyes (bilateral disease), and they tend to be diagnosed earlier in life. However, 10% to 15% of children with a tumor in only one eye also carry the hereditary form, so unilateral disease doesn’t rule out a genetic cause.
Children with the hereditary form face an elevated risk of developing multiple tumors in both eyes during early childhood. They also have a higher lifetime risk of other cancers later in life because the broken RB1 gene is present in every cell, not just the eyes.
Uveal Melanoma and the BAP1 Gene
Uveal melanoma is a cancer of the pigmented layer inside the eye and is the most common primary eye cancer in adults. The vast majority of cases arise from random DNA damage and have no hereditary component. But families with multiple cases of uveal melanoma, or clusters of certain other cancers, may carry a mutation in a gene called BAP1.
An inherited BAP1 mutation causes what’s known as BAP1 tumor predisposition syndrome. A global study of 181 families carrying this mutation found it increases the risk of four core cancer types: uveal melanoma, mesothelioma (a cancer of the lining of the lungs or abdomen), skin melanoma, and kidney cancer. The mutation is inherited in an autosomal dominant pattern, so each child of a carrier has a 50% chance of inheriting it.
If you’ve been diagnosed with uveal melanoma and have close relatives with any of those four cancers, that pattern could signal an underlying BAP1 mutation worth investigating through genetic testing.
Other Eye Tumors With Genetic Links
Several rarer eye and orbital tumors also have hereditary components:
- Medulloepithelioma: A rare childhood eye tumor caused by mutations in genes that regulate how other genes are expressed. One of the involved genes follows an autosomal dominant inheritance pattern.
- Optic nerve glioma: A tumor of the nerve connecting the eye to the brain, frequently linked to neurofibromatosis type 1 (NF1). Children with NF1, which is inherited in an autosomal dominant pattern, have a significantly higher risk of developing these tumors.
- Orbital rhabdomyosarcoma: A soft tissue cancer that can develop around the eye socket. Some cases are associated with Li-Fraumeni syndrome, a hereditary condition caused by mutations in a gene called TP53 that raises the risk of many cancer types.
- Plexiform neurofibromas: Benign nerve tumors that can grow around the eye and cause vision problems. These are also linked to NF1 and follow the same autosomal dominant inheritance.
In each of these cases, the eye tumor is one possible feature of a broader genetic syndrome, not a standalone inherited disease.
What “Autosomal Dominant” Means for Families
Most hereditary eye cancers follow an autosomal dominant pattern. In practical terms, this means you only need to inherit one copy of the mutated gene (from one parent) to be at increased risk. It doesn’t guarantee cancer will develop, but it significantly raises the odds compared to the general population.
If one parent carries the mutation, each pregnancy has a 50/50 chance of the child inheriting it. The mutation can also appear for the first time in a child with no family history, called a “de novo” mutation. That child could then pass it to their own future children. This is why some families are blindsided by a retinoblastoma diagnosis even with no known family history of eye cancer.
Screening for At-Risk Children
When a parent has hereditary retinoblastoma or carries a known RB1 mutation, their children need close monitoring from birth. Current guidelines from the American Association of Ophthalmic Oncologists and Pathologists recommend an eye exam within 24 hours of birth for at-risk infants. After that, the schedule is intensive:
- Birth to 8 weeks: Eye exams every 2 to 4 weeks
- 8 weeks to 12 months: Monthly exams under anesthesia
- 1 to 2 years: Every 2 months
- 2 to 3 years: Every 3 months
- 3 to 5 years: Every 4 to 6 months
- 5 to 7 years: Every 6 months (no anesthesia needed)
This schedule applies while the child is awaiting genetic test results or has confirmed carrier status. Frequent screening allows tumors to be caught when they’re small and more treatable. If genetic testing confirms the child did not inherit the mutation, this intensive schedule can be safely relaxed.
The Role of Genetic Testing and Counseling
Genetic testing can identify whether a person carries a hereditary mutation linked to eye cancer. For retinoblastoma, testing for RB1 mutations helps determine whether a child’s cancer is the hereditary or sporadic form, which directly affects how siblings and future children should be monitored. For uveal melanoma, testing for BAP1 mutations can reveal whether family members are at increased risk of eye and other cancers.
Genetic counseling has become an essential part of care for families affected by hereditary eye cancers. A counselor can explain what test results mean, outline the specific risks for each family member, and discuss reproductive options. For families who carry a known mutation and want to prevent passing it on, preimplantation genetic testing during IVF is one available strategy. This allows embryos to be screened for the mutation before pregnancy.
If you or a family member has been diagnosed with eye cancer, particularly retinoblastoma at any age, uveal melanoma before age 40, or bilateral eye tumors, these are strong indicators that genetic evaluation could benefit your family.